the aid library

Filter

5810

Monitoring global progess on addressing AMR

World Health Organization WHO (2018) C_WHO

The global tripartite self-assessment survey of country progress in addressing antimicrobial resistance (AMR) is a component of a broader approach for monitoring and evaluation of the global action plan on AMR. This report analyses the results of th ... more

Improved school-based deworming coverage through intersectoral coordination - The Kenya Experience

World Health Organization WHO - Regional Office Africa (2013) C_WHO

A national faecal examination of 27 729 schoolchildren from 395 schools carried out in 2008 indicated that intestinal parasitic worms affected an estimated five million (56.8%) children in Kenya. ... more

Ghana - Country Cooperation Strategy 2024 - 2028

World Health Organization WHO (2025) C_WHO

The development of the Country Cooperation Strategy (CCS) was based on a consultative and participatory process with strong commitment and support from the Ministry of Health of Ghana. The CCS draws on lessons from the implementation of the first, a ... more

Comprehensive cervical cancer prevention and control

World Health Organization (2013) C_WHO

This WHO Guidance Note advocates for a comprehensive approach to cervical cancer prevention and control and is aimed at senior policy makers and programme managers. It describes the need to deliver effective interventions across the female life course from childhood through to adulthood. These inclu ... more

WHO Guidelines on Integrated Care for Older People (ICOPE)
recommended

World Health Organization WHO (2017) C_WHO

he WHO Guidelines on Integrated Care for Older People (ICOPE) propose evidence-based recommendations for health care professionals to prevent, slow or reverse declines in the physical and mental cap ... more

The Abuja Declaration: Ten Years On

World Health Organization (WHO) World Health Organization (WHO) (2010) CC

Follow up to the so called Abuja Declaration ten years later: In April 2001, heads of state of African Union countries met and pledged to set a target of allocating at least 15% of their annual budget to improve the ... more

Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors 2023

World Health Organization WHO (2023) C_WHO

The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and ... more

Tanzania: The National Action Plan on AMR 2017-2022

The United Republic of Tanzania - Ministry of Health Community Development Gender Elderly and Children World Health Organization WHO (2017) C_WHO

This National Action Plan addresses actions needed to be taken in order to combat antimicrobial resistance (AMR) in the country. It is obligatory to raise awareness of antimicrobial resistance and p ... more

National Guidelines for Integrated Diseases Surveillance and Response Uganda

World Health Organization WHO, Regional Office of Africa; Ministry of Health Uganda (2021) C_WHO

3rd edition. In 2001, Uganda adapted the Integrated Disease Surveillance and Response (IDSR) developed by World Health ... more

Psychological first aid: Facilitator’s manual for orienting field workers
recommended

Leslie Snider, Alison Schafer, Mark van Ommeren et al. World Health Organization WHO (2013) C_WHO

This manual is designed to orient helpers to offer psychologicalfirst aid (PFA) to people following a serious crisis event. PFA involves humane, supportive and practical assistance for people who are distressed, in ways that respect their dignity, c ... more

IMAI district clinician manual: hospital care for adolescents and adults: guidelines for the management of illnesses with limited-resources. Vol. 2
recommended

World Health Organization WHO (2011) C_WHO

The manual is written for clinicians working at the district hospital (first-level referral care) who diagnose and manage sick adolescents and adults in resource constrained settings. It aims to support clinical reasoning, and to provide an effectiv ... more

Preventing suicide: A global imperative

World Health Organization (WHO) (2014) C_WHO

The report provides a global knowledge base on suicide and suicide attempts as well as actionable steps for countries based on their current resources and context to move forward in suicide prevention.

WHO guidelines on meningitis diagnosis, treatment and care
recommended

World Health Organization WHO (2025) C_WHO

The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, ... more

Implementing WHO evidence-based interventions for adolescents and young adults living with and affected by HIV

World Health Organization WHO (2024) C_WHO

Adolescents and young adults aged 10-24 remain underserved in the global response against HIV. Combination prevention, treatment and care programmes use a mix of evidence-based interventions to meet the current HIV prevention needs of adolescents an ... more

Guidelines for Prevention and Control of Chikungunya Fever - 2009

World Health Organization - Regional Office for South-East Asia (2009) CC

This guideline for the prevention and control of chikungunya fever (CF) is intended for use by all peripheral health workers in the Region and is based on the strategy outlined above. This documen ... more

WHO alcohol brief intervention training manual for primary care

World Health Organization (Europe) (2017) C_WHO

Alcohol contributes significantly to the disease and mortality burden in the WHO European Region, and primary health care systems play an important role i ... more

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID ... -19 The guidance includes updated risk rates for hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Maintaining a safe and adequate blood supply during Zika virus outbreaks

World Health Organization WHO (2016) C_WHO

Inerim Guidance. These guidelines have been developed in recognition that infection with Zika virus may present a risk to blood safety, and in consideration of the declaration on 1 February 2016 by ... more

WHO recommendations on antenatal care for a positive pregnancy experience

World Health Organization WHO (2016) C_WHO

This document is intended for a wide audience including national and local policymakers, implementers and managers of national and local maternal and child health programmes, non-governmental and other organizations and professional societies involv ... more

Malaria rapid diagnostic test performance. Results of WHO product testing of malaria RDTs round 8 (2016-2018). Summary

World Health Organization WHO; FIND; CDC (2018) C_WHO

This report, published in conjunction with a summary overview of results of rounds 1–8, is the eighth and final report in a series of laboratory-based evaluations of rapid diagnostic tests (RDTs) ... more